Can atorvastatin with metformin change the natural history of prostate cancer as characterized by molecular, metabolomic, imaging and pathological variables? A randomized controlled trial protocol
Matthew J. Roberts, John W. Yaxley, Geoffrey D. Coughlin, Troy R.J. Gianduzzo, Rachel C. Esler, Nigel T. Dunglison, Suzanne K. Chambers, Robyn J. Medcraft, Clement W.K. Chow, Horst Joachim Schirra, Renee S. Richards, Nicholas Kienzle, Macy Lu, Ian Brereton, Hema Samaratunga, Joanna Perry-Keene, Diane Payton, Chikara Oyama, Suhail A. Doi, Martin F. LavinRobert A. Gardiner*
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
7Citations
(Scopus)
Fingerprint
Dive into the research topics of 'Can atorvastatin with metformin change the natural history of prostate cancer as characterized by molecular, metabolomic, imaging and pathological variables? A randomized controlled trial protocol'. Together they form a unique fingerprint.